IL1B Gene - Interleukin 1 Beta

Pathway Diagram

flowchart TD
    IL1B["IL1B<br/>Interleukin-1 Beta"]
    NLRP3["NLRP3<br/>Inflammasome"]
    CASP1["CASP1<br/>Caspase-1"]
    PYCARD["PYCARD<br/>ASC Adapter"]
    
    Inflammasome_Complex["Inflammasome<br/>Complex"]
    Pro_IL1B["Pro-IL1B<br/>Precursor"]
    Mature_IL1B["Mature IL1B<br/>Active Cytokine"]
    
    Neuroinflammation["Neuroinflammation<br/>Process"]
    Microglia_Activation["Microglia<br/>Activation"]
    
    Alzheimer["Alzheimer's<br/>Disease"]
    Parkinson["Parkinson's<br/>Disease"]
    ALS["ALS<br/>Disease"]
    MS["Multiple<br/>Sclerosis"]
    
    Neurodegeneration["Neurodegeneration<br/>Outcome"]
    Therapeutic_Target["Therapeutic<br/>Target"]
    
    NLRP3 -->|"assembles"| Inflammasome_Complex
    PYCARD -->|"bridges"| Inflammasome_Complex
    CASP1 -->|"recruited to"| Inflammasome_Complex
    
    Inflammasome_Complex -->|"cleaves"| Pro_IL1B
    Pro_IL1B -->|"processed to"| Mature_IL1B
    Mature_IL1B -->|"is"| IL1B
    
    IL1B -->|"activates"| Neuroinflammation
    IL1B -->|"triggers"| Microglia_Activation
    Neuroinflammation -->|"promotes"| Neurodegeneration
    
    IL1B -->|"associated with"| Alzheimer
    IL1B -->|"regulates"| Parkinson
    IL1B -->|"expressed in"| ALS
    IL1B -->|"activates"| MS
    
    Alzheimer -->|"contributes to"| Neurodegeneration
    Parkinson -->|"contributes to"| Neurodegeneration
    ALS -->|"contributes to"| Neurodegeneration
    MS -->|"contributes to"| Neurodegeneration
    
    IL1B -->|"serves as"| Therapeutic_Target
    
    style IL1B fill:#006494
    style NLRP3 fill:#4a1a6b
    style CASP1 fill:#4a1a6b
    style PYCARD fill:#4a1a6b
    style Neuroinflammation fill:#ef5350
    style Microglia_Activation fill:#ef5350
    style Neurodegeneration fill:#5d4400
    style Alzheimer fill:#5d4400
    style Parkinson fill:#5d4400
    style ALS fill:#5d4400
    style MS fill:#5d4400
    style Therapeutic_Target fill:#1b5e20

Introduction

Il1B Gene Interleukin 1 Beta is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

This page provides comprehensive information about IL1B Gene, including its structure, normal function in the nervous system, and its role in neurodegenerative diseases.

Function

The IL1B gene encodes interleukin-1 beta (IL-1β), a pro-inflammatory cytokine member of the interleukin-1 family. IL-1β is a key mediator of the inflammatory response and plays a crucial role in the innate immune system. In the central nervous system, IL-1β is produced by microglia, astrocytes, and neurons in response to injury, infection, or disease-associated molecular patterns (DAMPs).

IL-1β binds to the interleukin-1 receptor type I (IL-1R1), forming a complex that activates the MyD88-dependent signaling pathway, leading to activation of NF-κB and MAP kinases. This results in the expression of additional inflammatory mediators, chemokines, and adhesion molecules.

Key Functions in the Nervous System:

• Neuroinflammation Regulation: IL-1β is a primary driver of neuroinflammation in neurodegenerative diseases

• Fever Induction: Acts on the hypothalamus to induce fever through prostaglandin synthesis

• Sleep Regulation: Influences non-rapid eye movement (NREM) sleep

• Pain Modulation: Involved in inflammatory pain sensitization

• Synaptic Plasticity: Modulates long-term potentiation (LTP) and memory formation

Disease Associations

Alzheimer’s Disease

IL-1β is heavily implicated in Alzheimer’s disease pathogenesis:

• Elevated IL-1β levels are found in the brains and CSF of AD patients

• IL-1β promotes amyloid-beta (Aβ) production and aggregation

• Enhances tau phosphorylation and neurofibrillary tangle formation

• Drives chronic neuroinflammation that contributes to neuronal loss

• IL1B polymorphisms (e.g., -511 C>T) have been associated with increased AD risk

Parkinson’s Disease

• IL-1β contributes to dopaminergic neuron death in the substantia nigra

• Elevated in the substantia nigra and striatum of PD patients

• polymorphisms in IL1B promoter region associated with PD susceptibility

• Mediates microglia activation and neuroinflammation in PD models

ALS (Amyotrophic Lateral Sclerosis)

• Elevated IL-1β in CSF and spinal cord of ALS patients

• Contributes to motor neuron death through inflammatory mechanisms

• IL-1β polymorphisms may influence disease progression

Neuroinflammation in Other Disorders

• Multiple Sclerosis (MS)

• Frontotemporal Dementia (FTD)

• Huntington’s Disease

• Traumatic Brain Injury (TBI)

Expression

IL1B is expressed in various brain regions with notable expression in:

• Hippocampus: High expression in CA1-CA3 regions and dentate gyrus

• Cortex: Particularly in layers II-III and V

• Thalamus: Moderate expression

• Hypothalamus: Involved in fever and sleep regulation

• Basal Ganglia: Including substantia nigra

Expression is dynamically regulated by:

• Neuronal activity

• Glial cell activation

• Pathological stimuli (Aβ, α-synuclein, mutant huntingtin)

Key Publications

1. Mrak RE, Griffin WS (2005). “Glia and their cytokines in progression of neurodegeneration.” Neurobiol Aging. 26(3):349-354. ^{1CitationPMID 15639313Open reference}(https://pubmed.ncbi.nlm.nih.gov/15639313/)

2. Griffin WS, et al. (2006). “Interleukin-1 mediates Alzheimer and Lewy body pathologies.” J Neuroinflammation. 3:5. ^{2CitationPMID 16504142Open reference}(https://pubmed.ncbi.nlm.nih.gov/16504142/)

3. Simoni AD, et al. (2019). “IL-1β in Alzheimer disease and other dementias.” J Neurol Sci. 407:116430. ^{3CitationPMID 31704562Open reference}(https://pubmed.ncbi.nlm.nih.gov/31704562/)

4. Kopper TJ, et al. (2022). “IL-1β signaling in CNS neurodegeneration.” Cell Mol Neurobiol. 42(7):2157-2171. ^{4CitationPMID 34247325Open reference}(https://pubmed.ncbi.nlm.nih.gov/34247325/)

5. Heneka MT, et al. (2015). “Neuroinflammation in Alzheimer’s disease.” Lancet Neurol. 14(4):388-405. ^{5CitationPMID 25792098Open reference}(https://pubmed.ncbi.nlm.nih.gov/25792098/)

Therapeutic Targeting

Background

The study of Il1B Gene Interleukin 1 Beta has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.